These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990 [Abstract] [Full Text] [Related]
23. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Tanizawa Y. Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323 [Abstract] [Full Text] [Related]
24. The treatment of pancreatic cancer. Yeo CJ, Cameron JL. Ann Chir Gynaecol; 2000 Mar; 89(3):225-33. PubMed ID: 11079793 [No Abstract] [Full Text] [Related]
30. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H. Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [Abstract] [Full Text] [Related]
33. No-touch pancreatectomy for invasive ductal carcinoma of the pancreas. Hirota M, Ogawa M. JOP; 2014 May 27; 15(3):243-9. PubMed ID: 24865535 [Abstract] [Full Text] [Related]
34. Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection. Shiba H, Misawa T, Fujiwara Y, Futagawa Y, Furukawa K, Haruki K, Iida T, Iwase R, Yanaga K. Anticancer Res; 2013 Sep 27; 33(9):4041-7. PubMed ID: 24023348 [Abstract] [Full Text] [Related]